Insys Chairman To Resign In Wake Of $225M Deal With Feds
Insys Therapeutics Inc. Chairman Steven Meyer will leave the post he's held since 2017, along with fellow board member Pierre Lapalme, the company said in a regulatory filing Thursday morning, a...To view the full article, register now.
Already a subscriber? Click here to view full article